AAAAAA
Results:
1-18
|
Results: 18
Authors:
ROSENTHAL MA
DENNIS D
LIEBES L
FURMANSKI P
CARON D
GARRISON L
WIPROVNICK J
PEACE D
ORATZ R
SPEYER J
CHACHOUA A
Citation: Ma. Rosenthal et al., BIOLOGIC ACTIVITY OF INTERLEUKIN-1 (IL-1)ALPHA IN PATIENTS WITH REFRACTORY MALIGNANCIES, Journal of immunotherapy, 21(5), 1998, pp. 371-378
Authors:
FERNANDO I
ORATZ R
EISENBERG P
CASTRO D
LEAVITT R
Citation: I. Fernando et al., INTRATUMORAL CISPLATIN EPINEPHRINE INJECTABLE GEL - PALLIATIVE TREATMENT OF ADVANCED SOLID TUMORS/, Annals of oncology, 9, 1998, pp. 663-663
Authors:
BYSTRYN JC
ORATZ R
SHAPIRO RL
HARRIS MN
ROSES DF
JACQUOTTE A
CHEN DL
RIVAS M
Citation: Jc. Bystryn et al., RANDOMIZED, DOUBLE-BLIND PHASE-III TRIAL OF A POLYVALENT, SHED, MELANOMA ANTIGEN VACCINE IN STAGE-III MELANOMA, Annals of oncology, 9, 1998, pp. 319-319
Authors:
ORATZ R
SEBASTIAN G
HAUSCHILD A
REISS H
CASTRO D
Citation: R. Oratz et al., INTRATUMORAL THERAPY WITH CISPLATIN EPINEPHRINE GEL AS A PALLIATIVE TREATMENT OF RECURRENT MALIGNANT-MELANOMA/, Annals of oncology, 9, 1998, pp. 692-692
Authors:
ROSENTHAL MA
ORATZ R
Citation: Ma. Rosenthal et R. Oratz, PHASE-II CLINICAL-TRIAL OF RECOMBINANT ALPHA-2B INTERFERON AND 13-CISRETINOIC ACID IN PATIENTS WITH METASTATIC MELANOMA, American journal of clinical oncology, 21(4), 1998, pp. 352-354
Authors:
BYSTRYN JC
ORATZ R
SHAPIRO R
HARRIS M
ROSES D
JACQUOTTE A
Citation: Jc. Bystryn et al., RANDOMIZED, DOUBLE-BLIND, CLINICAL-TRIAL OF A POLYVALENT MELANOMA VACCINE IN PATIENTS WITH STAGE-III MELANOMA, Journal of investigative dermatology, 110(4), 1998, pp. 498-498
Authors:
REYNOLDS SJ
CELIS E
SETTE A
SHAPIRO R
ORATZ R
BYSTRYN JC
Citation: Sj. Reynolds et al., HETEROGENEITY IN CD8-CELL RESPONSES TO MAGE-3, MELAN A( T)MART-1, GP100, TYROSINASE, MSH AND TRP-2 IN VACCINE-TREATED PATIENTS WITH MELANOMA/, Journal of investigative dermatology, 110(4), 1998, pp. 629-629
Authors:
HOCHSTER H
LIEBES L
SPEYER J
SORICH J
TAUBES B
ORATZ R
WERNZ J
CHACHOUA A
BLUM RH
ZELENIUCHJACQUOTTE A
Citation: H. Hochster et al., EFFECT OF PROLONGED TOPOTECAN INFUSION ON TOPOISOMERASE-1 LEVELS - A PHASE-I AND PHARMACODYNAMIC STUDY, Clinical cancer research, 3(8), 1997, pp. 1245-1252
Authors:
BYSTRYN JC
REYNOLDS SR
ORATZ R
SHAPIRO RL
HARRIS M
ROSES D
Citation: Jc. Bystryn et al., STIMULATION OF CD8-CELL RESPONSES TO MAGE-3 AND MART-1 BY IMMUNIZATION TO A SHED ANTIGEN MELANOMA VACCINE( T), Journal of investigative dermatology, 108(4), 1997, pp. 113-113
Authors:
REYNOLDS SR
ORATZ R
SHAPIRO RL
HAO P
YUN Z
FOTINO M
VUKMANOVIC S
BYSTRYN JC
Citation: Sr. Reynolds et al., STIMULATION OF CD8(-CELL RESPONSES TO MAGE-3 AND MELAN-A MART-1 BY IMMUNIZATION TO A POLYVALENT MELANOMA VACCINE() T), International journal of cancer, 72(6), 1997, pp. 972-976
Authors:
BYSTRYN JC
SHAPIRO RL
HARRIS M
ROSES DF
ORATZ R
Citation: Jc. Bystryn et al., USE OF VACCINES IN TREATMENT OF MALIGNANT-MELANOMA, Clinics in dermatology, 14(4), 1996, pp. 337-341
Authors:
WASSERHEIT C
FRAZEIN A
ORATZ R
SORICH J
DOWNEY A
HOCHSTER H
CHACHOUA A
WERNZ J
ZELENIUCHJACQUOTTE A
BLUM R
SPEYER J
Citation: C. Wasserheit et al., PHASE-II TRIAL OF PACLITAXEL AND CISPLATIN IN WOMEN WITH ADVANCED BREAST-CANCER - AN ACTIVE REGIMEN WITH LIMITING NEUROTOXICITY, Journal of clinical oncology, 14(7), 1996, pp. 1993-1999
Authors:
BYSTRYN JC
ORATZ R
SHAPIRO R
JOHNSTON D
HARRIS M
ROSES D
ZELENIUCHJACQUOTTE A
CHEN DL
LAX A
Citation: Jc. Bystryn et al., POTENTIATION OF MELANOMA VACCINE ACTIVITY BY IL-2 LIPOSOMES, Journal of investigative dermatology, 106(4), 1996, pp. 235-235
Authors:
SCHULTZ N
ORATZ R
CHEN DL
ZELENIUCHJACQUOTTE A
ABELES G
BYSTRYN JC
Citation: N. Schultz et al., EFFECT OF DETOX AS AN ADJUVANT FOR MELANOMA VACCINE, Vaccine, 13(5), 1995, pp. 503-508
Authors:
MILLER K
ABELES G
ORATZ R
ZELENIUCHJACQUOTTE A
CUI J
ROSES DF
HARRIS MN
BYSTRYN JC
Citation: K. Miller et al., IMPROVED SURVIVAL OF PATIENTS WITH MELANOMA WITH AN ANTIBODY-RESPONSETO IMMUNIZATION TO A POLYVALENT MELANOMA VACCINE, Cancer, 75(2), 1995, pp. 495-502
Authors:
CHACHOUA A
ORATZ R
LIEBES L
ALTER RS
FELICE A
PEACE D
VILCEK J
BLUM RH
Citation: A. Chachoua et al., PHASE IB TRIAL OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR COMBINED WITH MURINE MONOCLONAL-ANTIBODY R24 IN PATIENTS WITH METASTATICMELANOMA, Journal of immunotherapy with emphasis on tumor immunology, 16(2), 1994, pp. 132-141
Authors:
CHACHOUA A
ORATZ R
HOOGMOED R
CARON D
PEACE D
LIEBES L
BLUM RH
VILCEK J
Citation: A. Chachoua et al., MONOCYTE ACTIVATION FOLLOWING SYSTEMIC ADMINISTRATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Journal of immunotherapy with emphasis on tumor immunology, 15(3), 1994, pp. 217-224
Authors:
HOCHSTER H
LIEBES L
SPEYER J
SORICH J
TAUBES B
ORATZ R
WERNZ J
CHACHOUA A
RAPHAEL B
VINCI RZ
BLUM RH
Citation: H. Hochster et al., PHASE-I TRIAL OF LOW-DOSE CONTINUOUS TOPOTECAN INFUSION IN PATIENTS WITH CANCER - AN ACTIVE AND WELL-TOLERATED REGIMEN, Journal of clinical oncology, 12(3), 1994, pp. 553-559
Risultati:
1-18
|